<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been hypothesized that <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> develops as a consequence of an acquired genetic instability and the subsequent evolution of clonal populations with accumulated genetic errors </plain></SENT>
<SENT sid="1" pm="."><plain>Accordingly, human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and some <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesions</z:e> contain multiple genetic abnormalities not present in the <z:mpath ids='MPATH_458'>normal</z:mpath> tissues from which the <z:hpo ids='HP_0002664'>neoplasms</z:hpo> arose </plain></SENT>
<SENT sid="2" pm="."><plain>Barrett oesophagus (BE) is a <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant condition</z:e> which predisposes to oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EA) that can be biopsied prospectively over time because endoscopic surveillance is recommended for early detection of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, oesophagectomy specimens frequently contain the premalignant epithelium from which the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> arose </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">Neoplastic progression</z:e> in BE is associated with alterations in TP53 (also known as p53) and CDKN2A (also known as p16) and non-random losses of heterozygosity (LOH) </plain></SENT>
<SENT sid="5" pm="."><plain>Aneuploid or increased 4N populations occur in more than 90-95% of EAs, arise in premalignant epithelium and predict progression </plain></SENT>
<SENT sid="6" pm="."><plain>We have previously shown in small numbers of patients that disruption of TP53 and CDKN2A typically occurs before <z:mp ids='MP_0004024'>aneuploidy</z:mp> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Here, we determine the evolutionary relationships of non-random LOH, TP53 and CDKN2A mutations, CDKN2A CpG-island methylation and ploidy during <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Diploid cell progenitors with somatic genetic or epigenetic abnormalities in TP53 and CDKN2A were capable of clonal expansion, spreading to large regions of oesophageal mucosa </plain></SENT>
<SENT sid="9" pm="."><plain>The subsequent evolution of neoplastic progeny frequently involved bifurcations and LOH at 5q, 13q and 18q that occurred in no obligate order relative to each other, DNA-content <z:mp ids='MP_0004024'>aneuploidy</z:mp> or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Our results indicate that <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> is more complex than predicted by linear models </plain></SENT>
</text></document>